Seeing Is Believing

Currently out of the existing stock ratings of Jim Birchenough, 69 are a HOLD (31.36%), 149 are a BUY (67.73%), 2 are a SELL (0.91%).
Analyst Jim Birchenough, currently employed at WELLS FARGO, carries an average stock price target met ratio of 67.64% that have a potential upside of 41.24% achieved within 438 days. Previously, Jim Birchenough worked at BMO.
Jim Birchenough’s has documented 427 price targets and ratings displayed on 46 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on SGMO, Sangamo Therapeutics at 02-Jan-2025.
Analyst best performing recommendations are on ARNA (ARENA PHARMACEUTICALS).
The best stock recommendation documented was for ARNA (ARENA PHARMACEUTICALS) at 12/10/2021. The price target of $71 was fulfilled within 3 days with a profit of $21.06 (42.17%) receiving and performance score of 140.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Aug-2017
$30
6 years 1 months 1 days ago
(01-Sep-2020)
2/8 (25%)
$14.76 (96.85%)
30
Hold Since 25-Sep-2018
$20
$1.83 (10.07%)
$31
6 years 4 months 26 days ago
(06-May-2020)
1/2 (50%)
$4.76 (31.23%)
9
Hold Since 07-Oct-2019
$24
6 years 11 months 25 days ago
(07-Oct-2019)
3/4 (75%)
$5.96 (33.04%)
44
Buy Since 07-Oct-2019
$45
$26.83 (147.66%)
$45
6 years 11 months 25 days ago
(07-Oct-2019)
0/2 (0%)
$25.13 (126.47%)
Hold Since 07-Aug-2018
8 years 7 days ago
(25-Sep-2018)
3/3 (100%)
$-5.99 (-15.36%)
24
What Year was the first public recommendation made by Jim Birchenough?